Positive control RNA for the detection system of the N gene of the novel coronavirus (SARS-CoV-2).
This product is synthetic RNA that contains the full-length sequence of the Nucleocapsid Protein gene (N gene) of the novel coronavirus (SARS-CoV-2) and can be used as positive control RNA for detection systems targeting the N gene. Additionally, since a HindIII site is inserted within the sequence, it is possible to distinguish whether the amplification product originates from this product or from other templates in the event of contamination in the laboratory. 【Features】 - Can be used as positive control RNA for N gene detection systems - PCR products amplified from positive control RNA can be distinguished by restriction enzyme treatment For more details, please refer to the PDF document or feel free to contact us. *This product is a research reagent. It has not been approved or certified as an in vitro diagnostic drug or medical device.
Inquire About This Product
basic information
Please feel free to contact us.
Price information
Desired inclusion price: 20,000 yen (excluding tax)
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.